Teresa Cobo

Teresa Cobo

Auto-generated profile, based on publicly available information

Teresa Cobo

BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clinic and Hospital Sant Joan de Déu), Institut Clínic de Ginecología, Obstetrícia I Neonatología, Fetal i+D Fetal Medicine Research Center, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona. Barcelona, Spain; Center for Biomedical Research on Rare Diseases (CIBER-ER), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MKMarian Kacerovsky
Marian Kacerovsky
Peter CelecPeter Celec
Peter Celec
BVBarbora Vlkova
Barbora Vlkova
KSKristin Skogstrand
Kristin Skogstrand
DHDavid M Hougaard
David M Hougaard
BJBo Jacobsson
Bo Jacobsson
This study aimed to evaluate the amniotic fluid protein profiles and the intensity of intraamniotic inflammatory response to Ureaplasma spp. and other bacteria, using the multiplex xMAP technology. A retrospective cohort study was undertaken in the Department of Obstetrics and Gynecology, University Hospital Hradec Kralove, Czech Republic. A total of 145 pregnant women with preterm prelabor rupture of membranes between gestational age 24+0 and 36+6 weeks were included in the study. Amniocenteses were performed. The presence of Ureaplasma spp. and other bacteria was evaluated using 16S rRNA gene sequencing. The levels of specific proteins were determined using multiplex xMAP technology. The presence of Ureaplasma spp. and other bacteria in the amniotic fluid was associated with increased levels of interleukin (IL)-6, IL-8, IL-10, brain-derived neurotropic factor, granulocyte macrophage colony stimulating factor, monocyte chemotactic protein-1, macrophage inflammatory protein-1, and matrix metalloproteinasis-9. Ureaplasma spp. were also associated with increased levels of neurotropin-3 and triggering receptor expressed on myeloid cells-1. The presence of Ureaplasma spp. in the amniotic fluid is associated with a slightly different protein profile of inflammatory response, but the intensity of inflammatory response to Ureaplasma spp. is comparable with the inflammatory response to other bacteria.

1 January 2006 in International Journal of Gynecological Cancer
Verified
Journal Article
Closed access
PDF file
ASA. Sanjuán
A. Sanjuán
TCT. Cobo
T. Cobo
P(PAHISA, JAUME (ICGON)
PAHISA, JAUME (ICGON)
GEG. Escaramís
G. Escaramís
Jaume OrdiJaume Ordi
Jaume Ordi
JVJ.A. Vanrell
J.A. Vanrell

21 March 2013 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
PTPanagiotis Tsiartas
Panagiotis Tsiartas
MKMarian Kacerovsky
Marian Kacerovsky
IMIvana Musilova
Ivana Musilova
HHHelena Hornychova
Helena Hornychova
TCTeresa Cobo
Teresa Cobo
BJBo Jacobsson
Bo Jacobsson
Objective: To determine the impact of histological chorioamnionitis (HCA) and funisitis on neonatal outcome in preterm prelabor rupture of membranes (PPROM) pregnancies. Methods: Women with PPROM between 24 + 0 to 36 + 6 weeks of gestation, admitted to the Department of Obstetrics and Gynecology at the University Hospital Hradec Kralove in the Czech Republic, between July 2008 and October 2010, were enrolled in the study (n = 231). Results: The incidence of early-onset sepsis (EOS) differed significantly in neonates born to women with and without HCA, after adjustment for gestational age (11% versus 1%, p = 0.011). The incidence of EOS in neonates was also significantly different, after adjustment for gestational age, in cases with and without funisitis (18% versus 4%, p = 0.002). The same was also found for retinopathy of prematurity (ROP) cases with and without funisitis (23% versus 4%, p = 0.014), after adjustment for gestational age. Conclusions: HCA and funisitis increase the risk of adverse perinatal outcome in PPROM pregnancies.

26 April 2016 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Closed access
PDF file
ARAdriano Rodríguez‐Trujillo
Adriano Rodríguez‐Trujillo
TCTeresa Cobo
Teresa Cobo
IVIrene Vives
Irene Vives
JBJordi Bosch
Jordi Bosch
MKMarian Kacerovsky
Marian Kacerovsky
MPMontse Palacio
Montse Palacio

11 June 2014 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
EBElisenda Bonet-Carne
Elisenda Bonet-Carne
MPMontse Palacio
Montse Palacio
TCT. Cobo
T. Cobo
APA. Perez‐Moreno
A. Perez‐Moreno
MLM. Lopez
M. Lopez
EGEduard Gratacos
Eduard Gratacos
Objective: To develop and evaluate the performance of a novel method for predicting neonatal respiratory morbidity based on quantitative analysis of the fetal lung by ultrasound.Methods: More than 13 000 non‐clinical images and 900 fetal lung images were used to develop a computerized method based on texture analysis and machine learning algorithms, trained to predict neonatal respiratory morbidity risk on fetal lung ultrasound images. The method, termed ‘quantitative ultrasound fetal lung maturity analysis’ (quantusFLM™), was then validated blindly in 144 neonates, delivered at 28 + 0 to 39 + 0 weeks' gestation. Lung ultrasound images in DICOM format were obtained within 48 h of delivery and the ability of the software to predict neonatal respiratory morbidity, defined as either respiratory distress syndrome or transient tachypnea of the newborn, was determined.Results: Mean (SD) gestational age at delivery was 36 + 1 (3 + 3) weeks. Among the 144 neonates, there were 29 (20.1%) cases of neonatal respiratory morbidity. Quantitative texture analysis predicted neonatal respiratory morbidity with a sensitivity, specificity, positive predictive value and negative predictive value of 86.2%, 87.0%, 62.5% and 96.2%, respectively.Conclusions: Quantitative ultrasound fetal lung maturity analysis predicted neonatal respiratory morbidity with an accuracy comparable to that of current tests using amniotic fluid. Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd.

1 August 2011 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
TCTeresa Cobo
Teresa Cobo
MPMontse Palacio
Montse Palacio
MMMónica Martínez-Terrón
Mónica Martínez-Terrón
ANAleix Navarro-Sastre
Aleix Navarro-Sastre
JBJordi Bosch
Jordi Bosch
EGEduard Gratacos
Eduard Gratacos